Skip to main content
Premium Trial:

Request an Annual Quote

Danaher to Acquire Aldevron for $9.6B

NEW YORK – Danaher announced on Thursday that it has entered into a definitive agreement to acquire Aldevron for approximately $9.6 billion.

Fargo, North Dakota-based Aldevron manufactures plasmid DNA, mRNA, and proteins for biotechnology and pharmaceutical customers in research, clinical, and commercial applications. The firm was founded in 1998, employs around 600 people, and is privately held.

Aldevron will operate as a standalone company and brand within Danaher's Life Sciences segment, which includes firms such as Beckman Coulter Life Sciences, Cytiva, Pall, Integrated DNA Technologies, Sciex, and several others.

The Washington, DC-based conglomerate plans to finance the acquisition using cash on hand and/or proceeds from the issuance of commercial paper.

"Aldevron has made tremendous contributions to the advancement of cell, gene and other novel therapies and vaccines," said Danaher CEO Rainer Blair in a statement. "This acquisition will expand our capabilities into the important field of genomic medicine and help us support our customers and their critical mission to bring more life-saving therapies and vaccines to market faster."

Shares of Danaher were up approximately 3 percent at $251.63 in Thursday morning trade on the New York Stock Exchange.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.